Benchmark Holdings PLC Adoption of MRL for Ectosan Vet in Norway (4109F)

TIDMBMK

RNS Number : 4109F

Benchmark Holdings PLC

15 July 2021

15 July 2021

Benchmark Holdings plc

("Benchmark", the "Company" or the "Group")

Adoption of MRL for Ectosan (â) Vet in Norway

Benchmark Holdings, the aquaculture biotechnology company, is pleased to announce that the MRL (Maximum Residue Limit) for Ectosan (â) Vet has been adopted into the Agreement of the European Economic Area (the EEA Agreement); and today, has entered into Norwegian legislation completing the regulatory steps required for the commercialisation of Ectosan (â) Vet and CleanTreat (â) in Norway.

   Trond Williksen,   CEO, commented: 

"With the granting of the Marketing Authorisation on 2(nd) July, the MRL ratified by the European Commission and now in Norwegian legislation, we have completed the regulatory steps required to begin the commercialisation of Ectosan (â) Vet and CleanTreat (â) in Norway."

"We are excited to bring this much needed solution to the salmon industry, driving sustainability through improved animal welfare and yield while protecting the environment. "

Enquiries

 
Benchmark Holdings plc                      Tel: [phone] 
Trond Williksen, CEO 
 Septima Maguire, CFO 
 Ivonne Cantu, Investor Relations Director 
 
Numis (Broker and NOMAD)                    Tel: [phone] 
James Black / Freddie Barnfield / Duncan 
 Monteith 
 
MHP 
Katie Hunt /Alistair de Kare-Silver /       Tel: [phone] 
 Charlie Protheroe                           [e-mail] 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEADXSFDNFEFA

(END) Dow Jones Newswires

July 15, 2021 10:00 ET (14:00 GMT)